Results 131 to 140 of about 49,360 (273)

Striatal response to negative feedback in a stop signal task operates as a multi-value learning signal. [PDF]

open access: yesImaging Neurosci (Camb), 2023
Smith BJ   +5 more
europepmc   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao   +7 more
wiley   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon   +11 more
wiley   +1 more source

Inhibition of return emerges with non-predictive spatial cueing of the stop-signal

open access: yesFrontiers in Human Neuroscience
The ability to suppress an inappropriate response can be influenced by several factors, including providing information on where to pay attention. For example, the spatial prediction of the stop signal location enhances inhibitory control in a Stop ...
Md. Tanbeer Haque   +7 more
doaj   +1 more source

RNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Mitochondrial diseases are the most common inherited metabolic disorders, characterized by pronounced clinical and genetic heterogeneity that complicates molecular diagnosis. Although DNA‐based sequencing approaches have become standard in genetic testing, up to half of patients remain without a definitive diagnosis.
Zhimei Liu   +21 more
wiley   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio   +8 more
wiley   +1 more source

Poor Stop-Signal Task Performance: Mechanisms Revealed through Event-Related Brain Potentials

open access: yes, 2010
The stop-signal task has been used extensively in order to test abilities of inhibition as well as cognitive functioning. In previous experiments, a relatively large number of participants had to be excluded from analysis because of poor performance on ...
Schumacher, William M.
core  

Examining reaction time variability on the stop-signal task in the ABCD study. [PDF]

open access: yesJ Int Neuropsychol Soc, 2023
Epstein JN   +8 more
europepmc   +1 more source

Electrophysiological indices of response inhibition in the stop-signal task

open access: yes, 2009
Response inhibition is vital for the performance of everyday tasks, allowing us to stop and adjust inappropriate behaviour in accord with our external environment and our own internal directions, while a deficiency in this process is believed to lead to ...
Aneta Dimoska (20282373)
core  

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy